No Data
Announcement Highlights | In the first 11 months, SUNSHINE INS's original premium income exceeded 120 billion yuan; GCL TECH plans to allot up to 1.56 billion shares, net raising approximately 1.53 billion Hong Kong dollars.
In the first 11 months, SUNSHINE INS's original premium income exceeded 120 billion yuan; the major Shareholder of CHENGDU EXPWAY won a highway project worth over 10 billion yuan.
Shanghai INT Medical Instruments Eyes Majority Stake in Vascular Interventional Medical Device Firm
INT MEDICAL (01501.HK) plans to acquire at least 51% equity in Hangzhou Weiqiang Medical Technology.
On December 18, Guolonghui reported that INT MEDICAL (01501.HK) announced that on December 18, 2024, the company, the target company Hangzhou Weiqiang Medical Technology Co., Ltd., and other target group companies have signed a Memorandum of Understanding for Acquisition. According to this agreement, the company has conditionally agreed to acquire at least 51% of the controlling equity of the target company through capital increase and by purchasing shares from certain shareholders of the target company. According to the Memorandum of Understanding for Acquisition, the company has conditionally agreed to increase its capital in the target company by no less than 200 million RMB after the acquisition. According to the Memorandum of Understanding for Acquisition, the company or its designated third party must complete the acquisition.
Express News | Shanghai Int Medical Instruments - Agreed to Acquire Controlling Stake With at Least 51% Stake in Hangzhou Weiqiang Medical Technology
INT MEDICAL: (1) GRANT OF RESTRICTED SHARES UNDER THE SHARE INCENTIVE SCHEME; AND (2) CLARIFICATION ANNOUNCEMENT
INT MEDICAL: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO 2023 ANNUAL REPORT
This Analyst Just Downgraded Their Shanghai INT Medical Instruments Co., Ltd. (HKG:1501) EPS Forecasts
No Data
